Although long-term follow-up information is not available for this case, we anticipate that the simultaneous presence of two high-risk genetic abnormalities in leukemia cells (RCSD1-ABL1 fusion and IKZF1 deletion) would predict a very high risk of relapse. This evidence concerns the gene ABL1 and leukemia.